Cirrhosis
📧 Sign up to get email alerts when something new happens for Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension
A clinical trial evaluating the concentration ratio of estrogen and testosterone in male patients with cirrhosis and hypotension has been wi…
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility [Phase 3]
A Phase 3 trial evaluating rifaximin for covert hepatic encephalopathy with SIBO and GI dysmotility was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-07Clinical Trial Update: Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis. [NA]
A clinical trial evaluating midodrine for refractory or recurrent ascites in children with cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-11-18Clinical Trial Update: Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction [Phase 2, Phase 3]
The clinical trial evaluating transfer factor for cirrhosis-associated immune dysfunction was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-07-20Clinical Trial Update: Nalmefene in Patients With Alcoholic Compensated Cirrhosis for the Treatment of Alcohol Dependence. [Phase 3]
A Phase 3 trial evaluating nalmefene for alcohol dependence in patients with compensated alcoholic cirrhosis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients
A pilot study investigating peripheral endothelial function in patients with portal hypertension and cirrhosis has been withdrawn from the r…
-
CLINICAL_TRIALS withdrawal · 2018-03-13Clinical Trial Update: Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis [NA]
The clinical trial evaluating Vivomixx for neuroinflammation in patients with cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-27Clinical Trial Update: Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients [Phase 3]
Phase 3 trial evaluating prophylactic dosing of low molecular weight heparin in Child-Pugh B cirrhosis patients has been suspended.
-
CLINICAL_TRIALS withdrawal · 2017-11-28Clinical Trial Update: To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
This ClinicalTrials.gov entry indicates that the study evaluating the clinical course and organ failure in severe acute hepatitis with and w…
-
CLINICAL_TRIALS withdrawal · 2017-08-09Clinical Trial Update: Portal Vein Thrombosis in Cirrhosis
A clinical trial evaluating portal vein thrombosis in cirrhosis has been withdrawn; the listed conditions include hepatic vein thrombosis an…
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients [Phase 3]
A Phase 3 trial evaluating rifaximin for the secondary prevention of recurrent spontaneous bacterial peritonitis in cirrhotic patients has b…
-
CLINICAL_TRIALS withdrawal · 2016-03-11Clinical Trial Update: Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
A clinical trial evaluating the effect of music on attention and prospective memory in hepatic encephalopathy and cirrhosis has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-03-10Clinical Trial Update: The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis
A clinical trial evaluating whether transient elastography can predict clinical decompensation in patients with early cirrhosis was withdraw…
-
CLINICAL_TRIALS withdrawal · 2016-01-15Clinical Trial Update: Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects [Phase 2]
A Phase 2 trial comparing eplerenone with spironolactone for ascites due to liver cirrhosis has been withdrawn from further study.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis
A study investigating the impact of large-volume paracentesis on fatigue, sleep, and quality of life in cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) [NA]
A clinical trial evaluating lactulose versus polyethylene glycol for hepatic encephalopathy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-31Clinical Trial Update: Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis [NA]
A clinical trial evaluating the effect of midodrine on portal pressures in patients with cirrhosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-31Clinical Trial Update: Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE [Phase 3]
A Phase 3 trial evaluating thalidomide for secondary prophylaxis of gastrointestinal bleeding in cirrhotic patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-05Clinical Trial Update: Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients [Phase 4]
A Phase 4 clinical trial examining lipopolysaccharide binding protein and infectious events in cirrhotic patients has been withdrawn.